Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lineage Commitment01:21

Lineage Commitment

4.6K
Commitment is the  process whereby stem cells:
4.6K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.4K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.3K
2.3K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

4.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Correlation between GDF15, MMP7 and gastric cancer and its prognosis.

European review for medical and pharmacological sciences·2024
Same author

Effects of IL-1β and IL-18 induced by NLRP3 inflammasome activation on myocardial reperfusion injury after PCI.

European review for medical and pharmacological sciences·2019
Same author

Exploration of effect of Odanacatib on inhibiting orthodontic recurrence in rats and on CatK and IGF-1 mRNA.

European review for medical and pharmacological sciences·2019
Same author

Review of recent advances in the management of hypertrophic cardiomyopathy.

European review for medical and pharmacological sciences·2017
Same author

Upregulation of the ALDOA/DNA-PK/p53 pathway by dietary restriction suppresses tumor growth.

Oncogene·2017
Same author

SUMOylation in cardiac disorders - a review.

European review for medical and pharmacological sciences·2017

Related Experiment Video

Updated: Apr 12, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.9K

Pathways involved in the evolution of leukemic stem cells.

P-Y Zhang1, Y-J Yang, C-M Fu

  • 1Department of Hematology Cancer Center, Xuzhou Central Hospital, Xuzhou, Jiangsu, China. zpying58@126.com.

European Review for Medical and Pharmacological Sciences
|May 14, 2015
PubMed
Summary

Cancer stem cells, like leukemic stem cells (LSCs) from hematopoietic stem cells (HSCs), drive tumor growth. Targeting LSC pathways offers a promising strategy for treating lymphoblastic leukemia.

More Related Videos

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.0K
Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
10:03

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Published on: August 1, 2017

12.4K

Related Experiment Videos

Last Updated: Apr 12, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.9K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.0K
Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
10:03

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Published on: August 1, 2017

12.4K

Area of Science:

  • Oncology
  • Cell Biology
  • Stem Cell Research

Background:

  • Cancer evolution theories propose origins from any cell or adult stem cells.
  • Adult stem cells possess inherent self-renewal and differentiation capabilities, making them potential cancer origins.
  • Leukemic stem cells (LSCs) are derived from hematopoietic stem cells (HSCs) and drive leukemia progression.

Purpose of the Study:

  • To explore the origins and characteristics of cancer stem cells, particularly LSCs.
  • To understand the role of stem cells in cancer development and heterogeneity.
  • To identify potential therapeutic targets in cancer stem cell signaling pathways.

Main Methods:

  • Review of existing hypotheses on cancer cell origins.
  • Description of leukemic stem cell (LSC) characteristics and derivation from hematopoietic stem cells (HSCs).
  • Discussion of signaling cascades involved in cancer stem cell development.

Main Results:

  • Leukemic stem cells (LSCs) originate from hematopoietic stem cells (HSCs) and are responsible for continued tumorigenesis.
  • LSCs exhibit differentiation capabilities, contributing to the heterogeneity observed in leukemic cells.
  • Significant progress has been made in understanding cancer stem cells and their associated signaling pathways.

Conclusions:

  • Targeting pathways essential for LSC proliferation and self-renewal may lead to effective lymphoblastic leukemia treatments.
  • Further research into the formation of LSCs from HSCs is needed.
  • Cancer stem cell research is crucial for developing novel and potent cancer therapies.